{
    "eid": "2-s2.0-84899844415",
    "title": "In Silico screening for potent inhibitors against the NS3/4A protease of hepatitis C virus",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Drug Discovery",
            "@code": "3002"
        }
    ],
    "keywords": [
        "Hepatitis C virus",
        "NS3/4A protease",
        "Steered molecular dynamics simulations"
    ],
    "authors": [
        "Arthitaya Meeprasert"
    ],
    "citedby-count": 11,
    "ref-count": 95,
    "ref-list": [
        "Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice",
        "Structural Basis for Resistance of the Genotype 2b Hepatitis C Virus NS5B Polymerase to Site A Non-Nucleoside Inhibitors",
        "Genetic diversity and evolution of hepatitis C virus - 15 years on",
        "Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes",
        "An overview about hepatitis C: A devastating virus",
        "Hepatitis C virus infection",
        "Current and emerging therapeutic approaches to hepatitis C infection",
        "Current therapies for chronic hepatitis C",
        "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection",
        "Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial",
        "Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells",
        "Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection",
        "HCV NS3-4A serine protease.",
        "Development of novel antiviral therapies for hepatitis c virus",
        "Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target",
        "Combined x-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335",
        "Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding",
        "Future therapy of hepatitis C",
        "Refined structure of sindbis virus core protein and comparison with other chymotrypsin-like serine proteinase structures",
        "An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus",
        "Peptide-based inhibitors of the hepatitis C virus serine protease",
        "Product inhibition of the hepatitis C virus NS3 protease",
        "P1 and P1' optimization of [3,4]-bicycloproline P2 incorporated tetrapeptidyl \u03b1-ketoamide based HCV protease inhibitors",
        "Substrate specificity of the hepatitis C virus serine protease NS3",
        "Unravelling hepatitis C virus replication from genome to function",
        "Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase",
        "Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: Insights from molecular dynamics simulation, binding free energy calculation and network analysis",
        "Understanding the drug resistance mechanism of hepatitis C virus NS3/4A to ITMN-191 due to R155K, A156V, D168A/E mutations: A computational study",
        "The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease",
        "Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity",
        "Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses",
        "Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain",
        "Solution structure and dynamics of the single-chain hepatitis C virus NS3 rotease NS4A cofactor complex",
        "Hepatitis C treatments in current clinical development.",
        "Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)",
        "Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease",
        "Future of allopathic hepatitis C treatment.",
        "Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients",
        "Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir",
        "Characterization of resistance mutations against HCV ketoamide protease inhibitors",
        null,
        "In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335",
        "Why amantadine loses its function in influenza M2 mutants: MD simulations",
        "Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1",
        "Combinatorial design of avian influenza neuraminidase inhibitors containing pyrrolidine core with a reduced susceptibility to viral drug resistance",
        "Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations",
        "Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulations",
        "Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and venezuelan equine encephalitis viruses: Molecular dynamics simulations and free energy calculations",
        "Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex",
        "Computer-assisted analysis of the interactions of macrocyclic inhibitors with wild type and mutant D168A hepatitis C virus NS3 serine protease",
        "Exploring the P2 and P3 ligand binding features for Hepatitis C virus NS3 protease using some 3D QSAR techniques",
        "Discovery of narlaprevir (SCH 900518): A potent, second generation HCV NS3 serine protease inhibitor",
        "Discovery of SCH446211 (SCH6): A new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication",
        "\u03b1-Ketoamides, \u03b1-ketoesters and \u03b1-diketones as HCV NS3 protease inhibitors",
        "Discovery of a novel bicycloproline P2 bearing peptidyl \u03b1-ketoamide LY514962 as HCV protease inhibitor",
        "Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical species",
        "Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease",
        "Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors",
        "P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profile",
        "Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: Synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profiles",
        null,
        null,
        "Can we trust docking results? Evaluation of seven commonly used programs on PDBbind database",
        "An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes",
        "Computer based design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A serine protease inhibitors",
        "A new method for induced fit docking (genius) and its application to virtual screening of novel HCV NS3-4A protease inhibitors",
        "Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method",
        "Mechanical unfolding of acylphosphatase studied by single-molecule force spectroscopy and MD simulations",
        "How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system?",
        "Top leads for swine influenza A/H1N1 virus revealed by steered molecular dynamics approach",
        "Investigation of indazole unbinding pathways in CYP2E1 by molecular dynamics simulations",
        "Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino] carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0] hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization",
        "Inhibitors of hepatitis C virus NS3\u00b74A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics",
        "Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1",
        "How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?",
        "Understanding the molecular properties of doxorubicin filling inside and wrapping outside single-walled carbon nanotubes",
        "Gaussian 03, Revision C.02.",
        "The Amber biomolecular simulation programs",
        "AMBER 10.",
        "A Point-Charge Force Field for Molecular Mechanics Simulations of Proteins Based on Condensed-Phase Quantum Mechanical Calculations"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ho Chi Minh City",
            "affilname": "Vi\u1ec7n Khoa h\u1ecdc v\u00e0 C\u00f4ng ngh\u1ec7 T\u00ednh to\u00e1n",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Warsaw",
            "affilname": "Institute of Physics of the Polish Academy of Sciences",
            "affiliation-country": "Poland"
        }
    ],
    "funding": []
}